Royal London Asset Management LTD Danaher Corp Transaction History

Royal London Asset Management LTD

$39.3 Billion
Q1 2024

A detailed history of Royal London Asset Management LTD transactions in Danaher Corp stock. As of the latest transaction made, Royal London Asset Management LTD holds 316,417 shares of DHR stock, worth $76.1 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

316,417

Previous 315,023 0.44%

Holding current value

$76.1 Million

Previous $72.9 Million 8.42%

% of portfolio

0.2%

Previous 0.21%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$224.58 - $256.19 $313,064 - $357,128	1,394 Added 0.44%	316,417 $79 Million
Q4 2023 Feb 13, 2024	BUY	$185.1 - $233.13 $699,863 - $881,464	3,781 Added 1.21%	315,023 $72.9 Million
Q3 2023 Nov 14, 2023	BUY	$233.08 - $265.59 $4.75 Million - $5.42 Million	20,395 Added 7.01%	311,242 $77.2 Million
Q2 2023 Aug 11, 2023	BUY	$224.99 - $256.14 $12 Million - $13.7 Million	53,362 Added 22.47%	290,847 $69.8 Million
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $1.47 Million - $1.69 Million	6,114 Added 2.64%	237,485 $59.9 Million

Q4 2022 Feb 09, 2023	BUY	$241.42 - $282.29 $1.86 Million - $2.18 Million	7,718 Added 3.45%	231,371 $61.4 Million
Q2 2022 Aug 12, 2022	BUY	$237.11 - $299.66 $444,581 - $561,862	1,875 Added 0.85%	223,653 $56.7 Million
Q1 2022 May 13, 2022	BUY	$257.27 - $315.76 $1.56 Million - $1.92 Million	6,079 Added 2.82%	221,778 $65.1 Million
Q4 2021 Oct 18, 2022	SELL	$292.08 - $329.01 $2.55 Million - $2.87 Million	-8,737 Reduced 3.89%	215,699 $71 Million
Q4 2021 Jan 18, 2022	SELL	$292.08 - $329.01 $2.55 Million - $2.87 Million	-8,737 Reduced 3.89%	215,699 $71 Million
Q3 2021 Oct 18, 2022	SELL	$272.21 - $332.43 $1.56 Million - $1.91 Million	-5,734 Reduced 2.49%	224,436 $68.3 Million
Q3 2021 Nov 02, 2021	SELL	$272.21 - $332.43 $1.56 Million - $1.91 Million	-5,734 Reduced 2.49%	224,436 $68.3 Million
Q2 2021 Oct 18, 2022	BUY	$225.08 - $271.69 $1.47 Million - $1.77 Million	6,517 Added 2.91%	230,170 $61.8 Million
Q2 2021 Jul 14, 2021	SELL	$225.08 - $271.69 $1.25 Million - $1.51 Million	-5,556 Reduced 2.36%	230,170 $61.8 Million
Q1 2021 Oct 17, 2022	BUY	$212.38 - $245.9 $2.56 Million - $2.97 Million	12,073 Added 5.4%	235,726 $53.1 Million
Q1 2021 Apr 13, 2021	BUY	$212.38 - $245.9 $1.45 Million - $1.67 Million	6,808 Added 2.97%	235,726 $53.1 Million
Q4 2020 Jan 29, 2021	SELL	$212.5 - $245.46 $39.7 Million - $45.9 Million	-186,814 Reduced 44.94%	228,918 $50.9 Million
Q3 2020 Nov 04, 2020	SELL	$177.16 - $215.33 $151,294 - $183,891	-854 Reduced 0.2%	415,732 $87.7 Million
Q2 2020 Jul 31, 2020	SELL	$128.7 - $176.83 $4.56 Million - $6.27 Million	-35,436 Reduced 7.84%	416,586 $71.8 Million
Q1 2020 May 01, 2020	BUY	$121.39 - $169.05 $1.07 Million - $1.5 Million	8,851 Added 2.0%	452,022 $63.7 Million
Q4 2019 Feb 05, 2020	BUY	$133.47 - $153.48 $254,126 - $292,225	1,904 Added 0.43%	443,171 $67.7 Million
Q3 2019 Nov 12, 2019	BUY	$135.4 - $146.47 $412,563 - $446,294	3,047 Added 0.7%	441,267 $63.7 Million
Q2 2019 Jul 31, 2019	BUY	$124.88 - $143.73 $501,518 - $577,219	4,016 Added 0.92%	438,220 $62.6 Million
Q1 2019 Apr 30, 2019	BUY	$97.62 - $132.29 $3.85 Million - $5.22 Million	39,486 Added 10.0%	434,204 $0
Q4 2018 Jan 29, 2019	BUY	$94.85 - $109.54 $37.4 Million - $43.2 Million	394,718 New	394,718 $40.2 Million
Q3 2018 Nov 08, 2018	SELL	$98.13 - $108.9 $26.4 Million - $29.3 Million	-269,501 Closed	0 $0
Q2 2018 Sep 19, 2018	BUY	$96.1 - $103.24 $25.9 Million - $27.8 Million	269,501 New	269,501 $26.6 Million

Others Institutions Holding DHR

# of Institutions

2,372

Shares Held

559M

Call Options Held

3.54M

Put Options Held

3.99M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $175B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Danaher Corp Transaction History